ArticleCurrent cancer drug targets2024

Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer.

Yanglong Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.